Ascentage Pharma Announces Preclinical Data Demonstrating Olverembatinib’s Therapeutic…
Ascentage Pharma, a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, announced that a new…
Read More...
Read More...